- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03463122
Head Mount Display-based Virtual Reality Rehabilitation of Hemispatial Neglect
March 9, 2018 updated by: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea
Virtual Reality Based Visual Perception Evaluation and Rehabilitation-pilot Study
Head-mounted display based virtual reality rehabilitation for hemispatial neglect.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators examine about the efficacy of field-of-regard-focused visual exploration therapy implemented using a head-mounted display virtual reality system for hemispatial neglect rehabilitation following stroke.
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 01022
- National Rehabilitation Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- presence of left hemispatial neglect as demonstrated by a score above the cut-off on the line bisection test or star cancellation test of the Behavioral Inattention Test, or mild-to-moderate neglect-related functional impairment defined by a score of 1-20 points on the Catherine Bergego Scale
- age 19 to 65 years
- first-time right hemispheric ischemic or haemorrhagic stroke as evidenced by brain imaging and medical records
- a score >25 on the Mini-Mental State Examination
Exclusion Criteria:
- presence of oculomotor palsies or visual defects as assessed via standard neurological examination
- orthopaedic disorders affecting neck movement
- inability to maintain a seated position.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Training first
This group completed 20 sessions of a field of regard-focused visual exploration therapy program using an head mount display (five daily sessions per week over a period of four weeks) in addition to conventional therapy followed by four weeks of conventional therapy
|
field of regard-focused visual exploration therapy in addition to conventional therapy
Other Names:
conventional therapy for stroke rehabilitation
|
Other: Waiting first
This group completed four weeks of conventional therapy followed by 20 sessions of a field of regard-focused visual exploration therapy program using an head mount display (five daily sessions per week over a period of four weeks) in addition to conventional therapy.
|
field of regard-focused visual exploration therapy in addition to conventional therapy
Other Names:
conventional therapy for stroke rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Field of regard-response time
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
time interval between target onset and response with field of regard setting
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Change in Field of regard-success rate
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
percentage of correct responses (clicking the left or right mouse button in response to a blue or red target, respectively) with field of regard setting
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Change in Field of regard-head movement
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
sum of all quantified head-rotations with field of regard setting
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Field of view-response time
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
time interval between target onset and response with field of view setting
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Field of view-success rate
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
percentage of correct responses (clicking the left or right mouse button in response to a blue or red target, respectively) with field of view setting
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Line bisection test
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Participants were asked to bisect the given lines by marking the centre of each line using their preferred or unaffected hand
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Star cancellation test
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
The experimenter crossed out the two small, central stars of the sheet as an example, following which participants were asked to mark the remaining small stars.
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Catherine Bergego Scale
Time Frame: Baseline, 4 weeks from baseline, 8 weeks from baseline
|
a standardised checklist designed to detect the degree of neglect during everyday life via direct observation of functioning during ten tasks
|
Baseline, 4 weeks from baseline, 8 weeks from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Joon-Ho Shin, National Rehabilitation Center of Korea
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2014
Primary Completion (Actual)
October 30, 2016
Study Completion (Actual)
December 31, 2016
Study Registration Dates
First Submitted
March 5, 2018
First Submitted That Met QC Criteria
March 9, 2018
First Posted (Actual)
March 13, 2018
Study Record Updates
Last Update Posted (Actual)
March 13, 2018
Last Update Submitted That Met QC Criteria
March 9, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NRC-2014-04-022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on field of regard-focused visual exploration therapy
-
Vanderbilt University Medical CenterCompletedEstablishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field AnalyzerVisual Field Defect, PeripheralUnited States
-
Fondation Ophtalmologique Adolphe de RothschildTerminated
-
VA Office of Research and DevelopmentCompleted
-
University Hospital, LimogesNot yet recruitingRetinitis Pigmentosa Syndrome
-
Kubota Vision Inc.Completed
-
Kubota Vision Inc.Completed
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR); Ontario Neurotrauma FoundationCompletedAccidental Falls | Musculoskeletal EquilibriumCanada
-
Centre Hospitalier Universitaire de NīmesCompletedGlaucoma | Retinitis PigmentosaFrance
-
Haukeland University HospitalUnknownInsulin-dependent Diabetes Mellitus | Maturity-Onset Diabetes of the Young, Type 3 | Maturity Onset Diabetes of the Young, Type 1 | Childhood Diabetes MellitusNorway
-
Boehringer IngelheimCompletedAlzheimer DiseaseUnited States, Spain, Canada, United Kingdom, Germany, Italy, Netherlands, Portugal, Austria, Belgium, France, Poland